| P50 | author | Laurie Galvan | Q57780557 |
| P2093 | author name string | Carlos Cepeda | |
| | Elizabeth A Wang | |
| | Michael S Levine | |
| | Véronique M André | |
| P2860 | cites work | Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases | Q22008842 |
| | Therapeutic interventions for symptomatic treatment in Huntington's disease | Q24239893 |
| | Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter | Q24310836 |
| | Synaptic organisation of the basal ganglia | Q24544917 |
| | Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry | Q24630976 |
| | Age-dependent alterations of corticostriatal activity in the YAC128 mouse model of Huntington disease | Q24657764 |
| | A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 |
| | Optical deconstruction of parkinsonian neural circuitry | Q28238685 |
| | Feedforward and feedback inhibition in neostriatal GABAergic spiny neurons | Q28259633 |
| | Projection subtypes of rat neostriatal matrix cells revealed by intracellular injection of biocytin | Q28264640 |
| | Decrease in striatal enkephalin mRNA in mouse models of Huntington's disease | Q28513464 |
| | D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons | Q29615480 |
| | The functional anatomy of basal ganglia disorders | Q29617461 |
| | A gene expression atlas of the central nervous system based on bacterial artificial chromosomes | Q29617753 |
| | Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system. | Q52067929 |
| | Glutamate decarboxylase immunoreactive neurons in rat neostriatum: their morphological types and populations | Q68432439 |
| | Chemical anatomy of striatal interneurons in normal individuals and in patients with Huntington's disease | Q73209561 |
| | Optogenetics in neural systems | Q29618164 |
| | Differential loss of striatal projection neurons in Huntington disease | Q33637273 |
| | Distinct roles of GABAergic interneurons in the regulation of striatal output pathways | Q33720464 |
| | Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway | Q33888216 |
| | Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice | Q34098463 |
| | The thalamostriatal system: a highly specific network of the basal ganglia circuitry | Q34550491 |
| | Ramifications of the globus pallidus in the rat as indicated by patterns of immunohistochemistry | Q34707716 |
| | Differential electrophysiological changes in striatal output neurons in Huntington's disease. | Q34764514 |
| | The fate of the large striatal interneurons expressing calretinin in Huntington's disease | Q34830720 |
| | Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin | Q35013054 |
| | Altered Balance of Activity in the Striatal Direct and Indirect Pathways in Mouse Models of Huntington's Disease | Q35055022 |
| | Dichotomous anatomical properties of adult striatal medium spiny neurons | Q35607269 |
| | Dopaminergic signaling and striatal neurodegeneration in Huntington's disease | Q35839434 |
| | Glutamate receptor abnormalities in the YAC128 transgenic mouse model of Huntington's disease | Q36016647 |
| | Neurotransmitters and neuromodulators in the basal ganglia | Q36586002 |
| | Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated | Q36599964 |
| | A systematic review of the treatment studies in Huntington's disease since 1990. | Q36719669 |
| | Detection of Huntington's disease decades before diagnosis: the Predict-HD study | Q36941187 |
| | Re-emergence of striatal cholinergic interneurons in movement disorders | Q36955354 |
| | Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice | Q37072467 |
| | Dopamine tone regulates D1 receptor trafficking and delivery in striatal neurons in dopamine transporter-deficient mice. | Q37121377 |
| | Optogenetic manipulation of neural circuitry in vivo. | Q37855184 |
| | A history of optogenetics: the development of tools for controlling brain circuits with light | Q37923765 |
| | Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function. | Q37930190 |
| | Preferential loss of preproenkephalin versus preprotachykinin neurons from the striatum of Huntington's disease patients | Q38288534 |
| | Enkephalin regulates acute D2 dopamine receptor antagonist-induced immediate-early gene expression in striatal neurons | Q38323909 |
| | Evidence for specific cognitive deficits in preclinical Huntington's disease. | Q38452724 |
| | Chemical pathology of Huntington's disease | Q40217253 |
| | Striatal and nigral neuron subpopulations in rigid Huntington's disease: implications for the functional anatomy of chorea and rigidity-akinesia | Q41174270 |
| | Early loss of neostriatal striosome neurons in Huntington's disease | Q42487671 |
| | Diffusion tensor imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to clinical measures. | Q42496467 |
| | Differential modulation of excitatory and inhibitory striatal synaptic transmission by histamine. | Q42496623 |
| | Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models | Q42508054 |
| | Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease | Q42525075 |
| | Drd1a-tdTomato BAC transgenic mice for simultaneous visualization of medium spiny neurons in the direct and indirect pathways of the basal ganglia. | Q42525723 |
| | Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids. | Q43187066 |
| | Atrophy of the hypothalamic lateral tuberal nucleus in Huntington's disease | Q44250429 |
| | Differential morphology of pyramidal tract-type and intratelencephalically projecting-type corticostriatal neurons and their intrastriatal terminals in rats | Q44298778 |
| | Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons | Q44463501 |
| | Evidence for differential cortical input to direct pathway versus indirect pathway striatal projection neurons in rats. | Q45072853 |
| | Intratelencephalic corticostriatal neurons equally excite striatonigral and striatopallidal neurons and their discharge activity is selectively reduced in experimental parkinsonism | Q45218750 |
| | Loss of striatal histamine H2 receptors in Huntington's chorea but not in Parkinson's disease: comparison with animal models. | Q45289006 |
| | Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease | Q45289366 |
| | Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease | Q45291252 |
| | Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis | Q45292540 |
| | Nerve cell loss in the thalamic centromedian-parafascicular complex in patients with Huntington's disease | Q45292669 |
| | Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin | Q45292690 |
| | Differential loss of striatal projection systems in Huntington's disease: a quantitative immunohistochemical study | Q45293816 |
| | Orexin loss in Huntington's disease. | Q45295272 |
| | Selective sparing of a class of striatal neurons in Huntington's disease | Q45297134 |
| | Neuropathological classification of Huntington's disease | Q45297167 |
| | Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease | Q45298464 |
| | Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease | Q45299022 |
| | Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial | Q45300094 |
| | Functional increase of brain histaminergic signaling in Huntington's disease | Q45300658 |
| | Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis | Q45307235 |
| | Dopaminergic modulation of NMDA-induced whole cell currents in neostriatal neurons in slices: contribution of calcium conductances | Q46110140 |
| | Altered corticostriatal neurotransmission and modulation in dopamine transporter knock-down mice | Q48158205 |
| | Huntington disease | Q48465200 |
| | Tetrabenazine-induced depletion of brain monoamines: Mechanism by which desmethylimipramine protects cortical norepinephrine | Q48644262 |
| | Immunohistochemical evidence for a dynorphin immunoreactive striato-nigral pathway | Q48872243 |
| | Coordinated expression of dopamine receptors in neostriatal medium spiny neurons | Q48890601 |
| | The site of termination of afferent fibres on the neurones of the caudate nucleus | Q48896778 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 4.0 International | Q34179348 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Huntington's disease | Q190564 |
| | striatum | Q1319792 |
| P304 | page(s) | 17-25 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Journal of Huntington's Disease | Q24255728 |
| P1476 | title | Functional Differences Between Direct and Indirect Striatal Output Pathways in Huntington's Disease | |
| P478 | volume | 1 | |